Central venous catheters (CVCs) are becoming increasingly popular in outpatient and inpatient settings to provide long-term venous access. Their benefit is undeniable, but there are consequences and they can be startling. CVCs disrupt skin integrity and therefore leave the epidermis susceptible to fungus and bacteria. Infection may spread to the bloodstream and create organ dysfunction or death.
Nosocomial bloodstream infections prolong hospitalization by a mean of seven days and cost between $3,700 and $29,000 per case.¹
When a patient has a catheter, he or she is at constant risk for catheter-related bloodstream infection (CR-BSI). Factors at play are the catheter type, the frequency of access or manipulation, and the patient’s clinical status.²
CVCs are associated with a greater quantity and seriousness of infection than short peripheral catheters, partly because patients who need CVCs are often sicker, and their catheters are likely to be accessed more often.²
Approximately 90 percent of CR-BSIs occur with CVCs.¹
